HS
Hugh S. Griffith
Founder & Chief Executive Officer
NuCanaNuCana Pipeline
| Drug | Indication | Phase |
|---|
| NUC-3373 | Colorectal Cancer, Biliary Tract Cancer | Phase 2 |
| NUC-7738 | PD-1 Resistant Melanoma, Advanced Solid Tumors | Phase 2 |
| NUC-8232 | Various Solid Tumors | Phase 1 |